GI CANCERS

Latest News

Adding Nivolumab to Neoadjuvant Chemotherapy Spurs More Evaluation in Pancreatic Cancer
Adding Nivolumab to Neoadjuvant Chemotherapy Spurs More Evaluation in Pancreatic Cancer

June 18th 2024

Modified FOLFIRINOX with nivolumab in the neoadjuvant setting was associated with favorable rates of R0 resection in patients with borderline resectable pancreatic cancer.

Safe, Robust Responses Observed With Amphiphile Lymph Node-Targeted Vaccine in MRD+ PDAC and CRC
Safe, Robust Responses Observed With Amphiphile Lymph Node-Targeted Vaccine in MRD+ PDAC and CRC

June 12th 2024

Longer Follow-up Confirms Durability of Zanidatamab in Pretreated HER2+ BTC
Longer Follow-up Confirms Durability of Zanidatamab in Pretreated HER2+ BTC

June 2nd 2024

Perioperative Chemotherapy Prolongs OS in Esophageal Cancer
Perioperative Chemotherapy Prolongs OS in Esophageal Cancer

June 2nd 2024

FDA Acknowledges BLA of Zolbetuximab in HER2-, CLDN18.2+ Gastric/GEJ cancer
FDA Acknowledges BLA of Zolbetuximab in HER2-, CLDN18.2+ Gastric/GEJ cancer

May 31st 2024

Video Series
Video Interviews
Podcasts

More News